NCT00469352View on ClinicalTrials.gov

A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Macular Degeneration
Interventions
DRUG

Ranibizumab

Ranibizumab as needed

Trial Locations (1)

97239

Casey Eye Institute, Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT00469352 - A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD | Biotech Hunter | Biotech Hunter